Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
アクセス数 : 161 件
ダウンロード数 : 108 件
今月のアクセス数 : 1 件
今月のダウンロード数 : 3 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00051317
| File | |
| File | |
| File | |
| Title ( eng ) |
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
|
| Title ( jpn ) |
非小細胞肺癌患者の化学放射線療法におけるBIM欠失多型の臨床的意義について
|
| Creator |
Wakabayashi Yu
|
| Language |
eng
|
| Resource Type | doctoral thesis |
| Rights |
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. (c) 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
|
| Publish Type | Not Applicable (or Unknown) |
| Access Rights | open access |
| Source Identifier |
Wakabayashi, Y, Masuda, T, Fujitaka, K, et al. Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer. Cancer Sci. 2021; 112: 369-379
[DOI] https://doi.org/10.1111/cas.14711
|
| Dissertation Number | 甲第8544号 |
| Degree Name | |
| Date of Granted | 2021-03-23 |
| Degree Grantors |
広島大学
|
